Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Lumentum
LITE
$78B
| $2.03M | ﹤0.01% |
35,852
-809,703
| -96% | -$38.8M |
|
|
TGH
2302
DELISTED
Textainer Group Holdings limited
TGH
| $2.02M | ﹤0.01% |
209,750
+103,743
| +98% | +$1.23M |
|
|
SYRS
2303
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.02M | ﹤0.01% |
22,050
+9,580
| +77% | +$667K |
|
|
TRVN
2304
DELISTED
Trevena, Inc.
TRVN
| $2M | ﹤0.01% |
2,054
+939
| +84% | +$706K |
|
2305
JELD-WEN Holding
JELD
$170M
| $1.99M | ﹤0.01% |
+112,900
| New | +$2.03M |
|
|
BFYT
2306
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.99M | ﹤0.01% |
74,300
-645,900
| -90% | -$22.9M |
|
|
FRED
2307
DELISTED
Fred's Inc
FRED
| $1.98M | ﹤0.01% |
800,945
+211,400
| +36% | +$596K |
|
2308
Hallador Energy
HNRG
$730M
| $1.98M | ﹤0.01% |
375,900
+69,877
| +23% | +$378K |
|
2309
Full House Resorts
FLL
$84.3M
| $1.98M | ﹤0.01% |
978,092
+47,859
| +5% | +$106K |
|
2310
United Bankshares
UBSI
$6.68B
| $1.98M | ﹤0.01% |
54,500
+41,500
| +319% | +$1.5M |
|
|
SEAC
2311
DELISTED
Seachange International Inc
SEAC
| $1.97M | ﹤0.01% |
74,218
-4,817
| -6% | -$149K |
|
2312
Curis
CRIS
$3.91M
| $1.97M | ﹤0.01% |
2,470
+412
| +20% | +$197K |
|
|
CORV
2313
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.96M | ﹤0.01% |
620,948
-97,100
| -14% | -$314K |
|
2314
Vanguard Total International Stock ETF
VXUS
$164B
| $1.96M | ﹤0.01% |
+37,780
| New | +$1.92M |
|
|
VRTV
2315
DELISTED
VERITIV CORPORATION
VRTV
| $1.96M | ﹤0.01% |
+74,500
| New | +$2.28M |
|
|
SBBX
2316
DELISTED
SB One Bancorp Common Stock
SBBX
| $1.96M | ﹤0.01% |
90,000
+9,000
| +11% | +$197K |
|
2317
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $1.95M | ﹤0.01% |
+40,066
| New | +$1.93M |
|
2318
ImmunityBio
IBRX
$8.11B
| $1.95M | ﹤0.01% |
1,232,217
+155,000
| +14% | +$195K |
|
2319
Kewaunee Scientific
KEQU
$105M
| $1.94M | ﹤0.01% |
91,900
-5,200
| -5% | -$148K |
|
|
PHLT
2320
DELISTED
Performant Healthcare Inc
PHLT
| $1.93M | ﹤0.01% |
933,939
+6,239
| +0.7% | +$13.1K |
|
|
PFIE
2321
DELISTED
Profire Energy, Inc
PFIE
| $1.93M | ﹤0.01% |
1,080,100
-98,200
| -8% | -$174K |
|
|
FRTX
2322
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.92M | ﹤0.01% |
5,074
+1,791
| +55% | +$600K |
|
2323
Compugen
CGEN
$228M
| $1.91M | ﹤0.01% |
462,300
+109,700
| +31% | +$376K |
|
2324
Geospace Technologies
GEOS
$66.5M
| $1.91M | ﹤0.01% |
147,734
+54,734
| +59% | +$800K |
|
2325
BGC Group
BGC
$5.2B
| $1.91M | ﹤0.01% |
359,856
-2,325,400
| -87% | -$13.8M |
|
Similar funds
Jim Simons's Q1 2019 Portfolio in Review
As of Q1 2019, Jim Simons held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Jim Simons deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Jim Simons's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Jim Simons added most to Starbucks in Q1 2019, an estimated $618M increase.
- Jim Simons's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Jim Simons fully exited Apple in Q1 2019, selling an estimated $435M.
- Jim Simons's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Jim Simons opened 532 new positions and closed 465 in Q1 2019.
- Jim Simons's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.